Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab in urinary tract squamous cell carcinoma
NCT05038657Phase 2Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- May 2022
- Primary completion
- Jan 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in squamous cell carcinoma of the urinary tract (UTSCC), sponsored by University Hospital Southampton NHS Foundation Trust. Status: unknown.
02
Drugs
atezolizumab
03
Conditions
squamous cell carcinoma of the urinary tract (UTSCC)
Beyond the preview
Go deeper on NCT05038657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05038657.